Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ABBOTT LABORATORIESABT · Entity 2314 | Executive Vice President | February 27, 2015 | March 03, 2015 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ABBOTT LABORATORIES
Report date February 27, 2015 · Filed March 03, 2015
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common shares without par valueSEC Table I · non-derivative | Direct | 108,972 |
Reported balance
After 2015-02-27 transaction · row 1
1 source rowRow 1 · 2015-02-27 · Tax withholding · Disposed 11,530 · Balance 108,972 |
| Common shares without par valueSEC Table I · non-derivative | IndirectProfit Sharing Trust | 18,963 |
Reported balance
Holding disclosure · report date 2015-02-27 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 18,963 F1: Balance in the Abbott Laboratories Stock Retirement Trust as of February 27, 2015. |
| Common shares without par valueSEC Table I · non-derivative | IndirectBy self for son | 171 |
Reported balance
Holding disclosure · report date 2015-02-27 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 171 F2: The reporting person disclaims beneficial ownership of all securities held by his son. |
Filing footnotes · ownership attribution and instrument terms
F1: Balance in the Abbott Laboratories Stock Retirement Trust as of February 27, 2015.
F2: The reporting person disclaims beneficial ownership of all securities held by his son.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 07, 2007 Filed Aug 9, 2007 21:27 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 5,621 | $0.00 Strike: $42.42 | $0.00 |
DisclosureSEC source: 0001104659-07-061057 · a4.xml · derivative · entry 11 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 5,621 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| August 07, 2007 Filed Aug 9, 2007 21:27 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 8,185 | $0.00 Strike: $41.03 | $0.00 |
DisclosureSEC source: 0001104659-07-061057 · a4.xml · derivative · entry 10 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,454 Underlying: Common shares · 8,185 shares Expires 2014-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: Employee stock option including a replacement option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| August 07, 2007 Filed Aug 9, 2007 21:27 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 11,992 | $53.12 | $637,015.04 |
DisclosureSEC source: 0001104659-07-061057 · a4.xml · nonDerivative · entry 3 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,366 Read SEC document |
| August 07, 2007 Filed Aug 9, 2007 21:27 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 5,621 | $42.42 | $238,442.82 |
DisclosureSEC source: 0001104659-07-061057 · a4.xml · nonDerivative · entry 2 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,358 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 07, 2007 Filed Aug 9, 2007 21:27 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 8,185 | $41.03 | $335,844.46 |
DisclosureSEC source: 0001104659-07-061057 · a4.xml · nonDerivative · entry 1 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,737 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 03, 2007 Filed Aug 6, 2007 22:19 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 7,156 | $0.00 Strike: $51.21 | $0.00 |
DisclosureSEC source: 0001104659-07-059282 · a4.xml · derivative · entry 7 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,156 Underlying: Common Shares · 7,156 shares Expires 2014-08-02 F5 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| August 03, 2007 Filed Aug 6, 2007 22:19 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 8,333 | $0.00 Strike: $39.26 | $0.00 |
DisclosureSEC source: 0001104659-07-059282 · a4.xml · derivative · entry 6 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 8,333 shares Expires 2014-08-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| August 03, 2007 Filed Aug 6, 2007 22:19 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 7,156 | $51.21 | $366,458.76 |
DisclosureSEC source: 0001104659-07-059282 · a4.xml · nonDerivative · entry 2 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,552 Read SEC document |
| August 03, 2007 Filed Aug 6, 2007 22:19 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 8,333 | $39.26 | $327,153.58 |
DisclosureSEC source: 0001104659-07-059282 · a4.xml · nonDerivative · entry 1 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,708 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 01, 2007 Filed Aug 2, 2007 20:22 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 1,381 | $50.69 | $70,002.89 |
DisclosureSEC source: 0001104659-07-058357 · a4.xml · nonDerivative · entry 1 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,375 Read SEC document |
| March 01, 2007 Filed Mar 5, 2007 21:39 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 3,529 | $0.00 Strike: $37.42 | $0.00 |
DisclosureSEC source: 0001104659-07-016357 · a4.xml · derivative · entry 7 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 3,529 shares Expires 2007-03-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| March 01, 2007 Filed Mar 5, 2007 21:39 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 17,000 | $54.01 | $918,136.00 |
DisclosureSEC source: 0001104659-07-016357 · a4.xml · nonDerivative · entry 3 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,756 Read SEC document |
| March 01, 2007 Filed Mar 5, 2007 21:39 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 3,529 | $54.54 | $192,464.60 |
DisclosureSEC source: 0001104659-07-016357 · a4.xml · nonDerivative · entry 2 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,756 Read SEC document |
| March 01, 2007 Filed Mar 5, 2007 21:39 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 3,529 | $37.42 | $132,065.41 |
DisclosureSEC source: 0001104659-07-016357 · a4.xml · nonDerivative · entry 1 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,285 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 20, 2007 Filed Feb 20, 2007 22:55 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 1,776 | $52.49 | $93,222.24 |
DisclosureSEC source: 0001104659-07-012362 · a4.xml · nonDerivative · entry 6 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,756 Read SEC document |
| February 18, 2007 Filed Feb 20, 2007 22:55 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 1,222 | $52.49 | $64,142.78 |
DisclosureSEC source: 0001104659-07-012362 · a4.xml · nonDerivative · entry 5 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,532 Read SEC document |
| February 17, 2007 Filed Feb 20, 2007 22:55 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 3,486 | $52.49 | $182,980.14 |
DisclosureSEC source: 0001104659-07-012362 · a4.xml · nonDerivative · entry 4 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,754 Read SEC document |
| February 16, 2007 Filed Feb 20, 2007 22:55 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 83,000 | $0.00 Strike: $52.54 | $0.00 |
DisclosureSEC source: 0001104659-07-012362 · a4.xml · derivative · entry 10 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,000 Underlying: Common shares · 83,000 shares Expires 2017-02-15 F7 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The option becomes exercisable in annual increments of 27,667 on 02/16/2008, 27,667 on 02/16/2009 and 27,666 on 02/16/2010. Read SEC document |
| February 16, 2007 Filed Feb 20, 2007 22:55 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 17,000 | $52.54 | $893,180.00 |
DisclosureSEC source: 0001104659-07-012362 · a4.xml · nonDerivative · entry 3 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,240 F2 · kind: These shares represent a retention award of restricted stock under the Abbott Laboratories 1996 Incentive Stock Program. The awards generally vest on the third anniversary of their grant date and include the right to have stock withheld for tax purposes. Read SEC document |
| February 16, 2007 Filed Feb 20, 2007 22:55 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 20,400 | $52.54 | $1,071,816.00 |
DisclosureSEC source: 0001104659-07-012362 · a4.xml · nonDerivative · entry 2 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,240 F1 · kind: These shares represent performance vested restricted stock awards under the Abbott Laboratories 1996 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 15, 2007 Filed Feb 20, 2007 22:55 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 7,101 | $52.70 | $374,222.70 |
DisclosureSEC source: 0001104659-07-012362 · a4.xml · nonDerivative · entry 1 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,840 Read SEC document |
| January 31, 2007 Filed Feb 3, 2007 01:26 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 1,879 | $0.00 Strike: $53.19 | $0.00 |
DisclosureSEC source: 0001104659-07-006983 · a4.xml · derivative · entry 23 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,879 Underlying: common shares · 1,879 shares Expires 2008-02-12 F5 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 31, 2007 Filed Feb 3, 2007 01:26 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 13,270 | $0.00 Strike: $53.19 | $0.00 |
DisclosureSEC source: 0001104659-07-006983 · a4.xml · derivative · entry 22 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,270 Underlying: common shares · 13,270 shares Expires 2013-02-13 F5 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 31, 2007 Filed Feb 3, 2007 01:26 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 17,920 | $0.00 Strike: $53.19 | $0.00 |
DisclosureSEC source: 0001104659-07-006983 · a4.xml · derivative · entry 21 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,920 Underlying: common shares · 17,920 shares Expires 2014-02-19 F5 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 31, 2007 Filed Feb 3, 2007 01:26 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 13,588 | $0.00 Strike: $53.19 | $0.00 |
DisclosureSEC source: 0001104659-07-006983 · a4.xml · derivative · entry 20 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,588 Underlying: common shares · 13,588 shares Expires 2014-08-02 F5 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 31, 2007 Filed Feb 3, 2007 01:26 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 7,033 | $0.00 Strike: $45.47 | $0.00 |
DisclosureSEC source: 0001104659-07-006983 · a4.xml · derivative · entry 19 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 7,033 shares Expires 2007-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 31, 2007 Filed Feb 3, 2007 01:26 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 2,875 | $0.00 Strike: $34.77 | $0.00 |
DisclosureSEC source: 0001104659-07-006983 · a4.xml · derivative · entry 18 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 2,875 shares Expires 2008-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 31, 2007 Filed Feb 3, 2007 01:26 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 3,941 | $0.00 Strike: $27.43 | $0.00 |
DisclosureSEC source: 0001104659-07-006983 · a4.xml · derivative · entry 17 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 3,941 shares Expires 2007-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 31, 2007 Filed Feb 3, 2007 01:26 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 15,481 | $0.00 Strike: $42.42 | $0.00 |
DisclosureSEC source: 0001104659-07-006983 · a4.xml · derivative · entry 16 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,621 Underlying: common shares · 15,481 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 31, 2007 Filed Feb 3, 2007 01:26 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 21,281 | $0.00 Strike: $41.03 | $0.00 |
DisclosureSEC source: 0001104659-07-006983 · a4.xml · derivative · entry 15 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,639 Underlying: common shares · 21,281 shares Expires 2014-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 31, 2007 Filed Feb 3, 2007 01:26 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 16,667 | $0.00 Strike: $39.26 | $0.00 |
DisclosureSEC source: 0001104659-07-006983 · a4.xml · derivative · entry 14 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,333 Underlying: common shares · 16,667 shares Expires 2014-08-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 31, 2007 Filed Feb 3, 2007 01:26 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 48,689 | $53.19 | $2,589,767.91 |
DisclosureSEC source: 0001104659-07-006983 · a4.xml · nonDerivative · entry 10 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,941 Read SEC document |
| January 31, 2007 Filed Feb 3, 2007 01:26 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 7,033 | $53.04 | $373,030.32 |
DisclosureSEC source: 0001104659-07-006983 · a4.xml · nonDerivative · entry 9 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,630 Read SEC document |
| January 31, 2007 Filed Feb 3, 2007 01:26 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 7,033 | $45.47 | $319,806.69 |
DisclosureSEC source: 0001104659-07-006983 · a4.xml · nonDerivative · entry 8 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,663 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 31, 2007 Filed Feb 3, 2007 01:26 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 2,875 | $34.77 | $99,971.51 |
DisclosureSEC source: 0001104659-07-006983 · a4.xml · nonDerivative · entry 7 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,630 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 31, 2007 Filed Feb 3, 2007 01:26 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 3,941 | $27.43 | $108,112.66 |
DisclosureSEC source: 0001104659-07-006983 · a4.xml · nonDerivative · entry 6 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,755 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 31, 2007 Filed Feb 3, 2007 01:26 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 15,481 | $42.42 | $656,704.02 |
DisclosureSEC source: 0001104659-07-006983 · a4.xml · nonDerivative · entry 5 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,814 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 31, 2007 Filed Feb 3, 2007 01:26 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 21,281 | $41.03 | $873,195.61 |
DisclosureSEC source: 0001104659-07-006983 · a4.xml · nonDerivative · entry 4 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,333 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 31, 2007 Filed Feb 3, 2007 01:26 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 16,667 | $39.26 | $654,346.42 |
DisclosureSEC source: 0001104659-07-006983 · a4.xml · nonDerivative · entry 3 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,052 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 06, 2006 Filed Feb 3, 2007 01:26 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GiftCommon shares without par value | 290 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-07-006983 · a4.xml · nonDerivative · entry 2 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,385 Read SEC document |
| April 03, 2006 Filed Apr 4, 2006 14:47 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 10,000 | $42.41 | $424,100.00 |
DisclosureSEC source: 0001104659-06-021960 · a4.xml · nonDerivative · entry 1 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,675 F1 · kind: This sale was made pursuant to a previously adopted plan complying with rule 10b5-1(c). The plan was adopted on February 7, 2006. Read SEC document |
| March 16, 2006 Filed Feb 3, 2007 01:26 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GiftCommon shares without par value | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-07-006983 · a4.xml · nonDerivative · entry 12 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · Anne Marie Landgraf Living Trust Disclosed balance after: 25,000 F2 · balance_after: Held in the Anne Marie Landgraf Living Trust. The reporting person and his spouse are co-trustees of the trust. The trust is revocable by his spouse. Read SEC document |
| March 16, 2006 Filed Feb 3, 2007 01:26 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GiftCommon shares without par value | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-07-006983 · a4.xml · nonDerivative · entry 1 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,675 Read SEC document |
| February 21, 2006 Filed Feb 22, 2006 22:56 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 310 | $43.86 | $13,596.60 |
DisclosureSEC source: 0001104659-06-011234 · a4.xml · nonDerivative · entry 3 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,675 Read SEC document |
| February 18, 2006 Filed Feb 22, 2006 22:56 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 1,146 | $44.15 | $50,595.90 |
DisclosureSEC source: 0001104659-06-011234 · a4.xml · nonDerivative · entry 1 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,485 Read SEC document |
| February 17, 2006 Filed Feb 22, 2006 22:56 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 83,000 | $0.00 Strike: $44.16 | $0.00 |
DisclosureSEC source: 0001104659-06-011234 · a4.xml · derivative · entry 7 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,000 Underlying: Common shares · 83,000 shares Expires 2016-02-16 F6 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The option becomes exercisable in annual increments of 27,667 on 02/17/2007, 27,667 on 02/17/2008 and 27,666 on 02/17/2009. Read SEC document |
| February 17, 2006 Filed Feb 22, 2006 22:56 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 26,500 | $44.16 | $1,170,240.00 |
DisclosureSEC source: 0001104659-06-011234 · a4.xml · nonDerivative · entry 2 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,985 F1 · kind: These shares represent performance vested restricted stock awards under the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The awards have a 5 year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 15, 2006 Filed Feb 17, 2006 00:03 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 9,738 | $0.00 Strike: $43.73 | $0.00 |
DisclosureSEC source: 0001104659-06-010253 · a4.xml · derivative · entry 12 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,738 Underlying: common shares · 9,738 shares Expires 2008-02-12 F5 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| February 15, 2006 Filed Feb 17, 2006 00:03 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 11,383 | $0.00 Strike: $34.77 | $0.00 |
DisclosureSEC source: 0001104659-06-010253 · a4.xml · derivative · entry 11 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,875 Underlying: common shares · 11,383 shares Expires 2008-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| February 15, 2006 Filed Feb 17, 2006 00:03 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 9,738 | $43.73 | $425,842.74 |
DisclosureSEC source: 0001104659-06-010253 · a4.xml · nonDerivative · entry 5 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,631 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.